STAA Q3 2021 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q3 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$58M+23.9% YoY

Gross Profit

$45M77.6% margin

Operating Income

$8M13.4% margin

Net Income

$6M10.3% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

-6.4%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$19M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$325M

Total Liabilities

$75M

Stockholders' Equity

$249M

Cash & Equivalents

$196M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$47M	+23.9%
Gross Profit	$45M	$35M	+29.9%
Operating Income	$8M	$5M	+60.5%
Net Income	$6M	$4M	+54.7%

Revenue Segments

Implantable Collamer Lenses

$54M93%

Cataract Intraocular Lenses

$3M4%

Other Surgical Products

$2M3%